Wedbush Maintains Neutral on Gossamer Bio, Lowers Price Target to $32
Benzinga Newsdesk 12 hours ago
Analyst RatingsNewsPrice Target
Wedbush analyst Laura Chico maintains Gossamer Bio (NASDAQ:GOSS) with a Neutral and lowers the price target from $80 to $32.
Wedbush analyst Laura Chico maintains Gossamer Bio (NASDAQ:GOSS) with a Neutral and lowers the price target from $80 to $32.